Vascular B1 kinin receptors in patients with congestive heart failure

Area of Science:

• Cardiovascular pharmacology
• Kinin-receptor interactions
• Human forearm circulation

Background:

• Animal models suggest a vasomotor role for the B1 kinin receptor in cardiovascular disease.
• Conflicting data exist regarding B1 and B2 receptor roles, potentially due to cross-talk.
• Angiotensin-converting enzyme inhibition (ACEi) in heart failure complicates receptor function interpretation.

Purpose of the Study:

• To test the hypothesis that B1 receptor stimulation causes vasodilation and tissue plasminogen activator (t-PA) release in the human forearm when B2 receptor signaling is inhibited.
• To investigate potential cross-talk between B1 and B2 kinin receptors in the human peripheral circulation.
• To clarify the role of B1 kinin receptors in cardiovascular disease states.

Main Methods:

• Forearm blood flow was measured in 16 heart failure patients receiving ACEi.
• Double-blinded crossover studies involved intrabrachial infusions of B1 antagonist, B1 agonist, B2 agonist (bradykinin), and sodium nitroprusside.
• Infusions were conducted alone or with a B2 antagonist (HOE-140) to assess receptor cross-talk and function.

Main Results:

• HOE-140 (B2 antagonist) abolished bradykinin-induced vasodilation and t-PA release but did not affect basal vascular tone.
• B1 receptor agonism or antagonism did not alter forearm blood flow or t-PA release, even with B2 receptor blockade.
• These findings indicate no significant cross-talk between B1 and B2 kinin receptors in the human peripheral circulation.

Conclusions:

• The study does not support a role for cross-talk between B1 and B2 kinin receptors in the human peripheral circulation.
• B1 receptor stimulation does not appear to mediate vasodilation or t-PA release in this context.
• Further research may be needed to fully elucidate the complex roles of kinin receptors in cardiovascular diseases.